Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: RORγt inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthma

Fig. 1

Representative photomicrographs of bronchial biopsies from a healthy individual and a severe asthma patient (a) stained for IL-17 (green staining; arrows). The bar indicates 20 µm. Correlation between the number of IL-17 positively staining cells and tissue neutrophils in severe asthma patients (b). Cluster analysis of UBIOPRED bronchial biopsy transcriptome using Th2 and Th17 surrogate genes published by Choy et al., SciTransMed, 2015 (c)

Back to article page